Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1875 of 3284 entries
View as:

A Study of AZD4901 in Females With Polycystic Ovary Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01872078 Org: User:
Start: 06/30/13 End: 07/31/14 Due: 07/31/15

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

Phase: N/A Priority: Normal
NCT ID: NCT00688454 Org: User:
Start: 02/28/07 End: 01/31/08 Due: 01/31/09

Dyslipidemia Management in Chinese Post Stroke Patients

Phase: N/A Priority: Normal
NCT ID: NCT01897883 Org: User:
Start: 07/31/13 End: 08/31/14 Due: 08/31/15

A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants

Phase: N/A Priority: Normal
NCT ID: NCT06368440 Org: User:
Start: 05/15/24 End: 12/23/24 Due: 12/23/25

Nexium Dyspepsia/AST

Phase: N/A Priority: Normal
NCT ID: NCT00251914 Org: User:
Start: 12/31/02 End: 01/31/05 Due: 01/31/06

Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT00999063 Org: User:
Start: 12/31/09 End: 02/28/11 Due: 02/28/12

Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids

Phase: N/A Priority: Normal
NCT ID: NCT02449473 Org: User:
Start: 09/29/15 End: 06/21/17 Due: 06/21/18

National Survey on GERD Patients (Adults and Children)

Phase: N/A Priority: Normal
NCT ID: NCT00833573 Org: User:
Start: 01/31/09 End: 10/31/09 Due: 10/31/10

To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients

Phase: N/A Priority: Normal
NCT ID: NCT05866276 Org: User:
Start: 06/22/23 End: 05/31/24 Due: 05/31/25

of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

Phase: N/A Priority: Normal
NCT ID: NCT00925717 Org: User:
Start: 05/31/09 End: 10/31/09 Due: 10/31/10

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

Phase: N/A Priority: Normal
NCT ID: NCT03043872 Org: User:
Start: 03/27/17 End: 12/31/25 Due: 12/31/26

Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT02640742 Org: User:
Start: 12/18/15 End: 06/01/16 Due: 06/01/17

A Drug-Drug Interaction Study Between AZD1981 and Pravastatin to Study the Effect of AZD1981 on the Kinetics of Pravastatin

Phase: N/A Priority: Normal
NCT ID: NCT01254461 Org: User:
Start: 02/28/11 End: 04/30/11 Due: 04/30/12

Extension Study for 2993-112

Phase: N/A Priority: Normal
NCT ID: NCT01789957 Org: User:
Start: 09/30/02 End: 06/30/04 Due: 06/30/05

REalWorld Insights on the INitiation and Treatment Duration of ticagrEloR & Other Oral Antiplatelets (OAP) in Patients With Acute Coronary Syndrome (ACS) in Be/Lux.

Phase: N/A Priority: Normal
NCT ID: NCT02190123 Org: User:
Start: 09/30/14 End: 01/31/15 Due: 01/31/16

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00544986 Org: User:
Start: 06/30/05 End: 11/30/07 Due: 11/30/08

Efficacy and Tolerability of Zolmitriptan Nasal Spray

Phase: N/A Priority: Normal
NCT ID: NCT00617747 Org: User:
Start: 09/30/02 End: 06/30/03 Due: 06/30/04

Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia

Phase: N/A Priority: Normal
NCT ID: NCT01352897 Org: User:
Start: 08/31/10 End: 12/31/10 Due: 12/31/11

To Evaluate the Bioavailability of a Tablet of AZD1656

Phase: N/A Priority: Normal
NCT ID: NCT00817505 Org: User:
Start: 12/31/08 End: 09/30/09 Due: 09/30/10

A Single Arm, Tolerability and Safety Phase IV Study of Fulvestrant(Faslodex® ) as 2nd Line and Later Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02447328 Org: User:
Start: 05/29/15 End: 09/16/20 Due: 09/16/21

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00837967 Org: User:
Start: 01/31/09 End: 07/31/09 Due: 07/31/10

Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related Comorbidity

Phase: N/A Priority: Normal
NCT ID: NCT06579092 Org: User:
Start: 10/08/24 End: 12/09/25 Due: 12/09/26

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00320268 Org: User:
Start: 04/30/06 End: 05/31/07 Due: 05/31/08

Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02588105 Org: User:
Start: 11/10/15 End: 07/26/22 Due: 07/26/23

Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

Phase: N/A Priority: Normal
NCT ID: NCT00658255 Org: User:
Start: 10/31/02 End: 05/31/03 Due: 05/31/04